SEC Form 4 · accession 0000313143-26-000111
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ellen M Zane
Director
Period of report
Jul 24, 2026
Accepted (ET)
Jul 28, 2026 · 5:02 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 24, 2026 | A | 2,538 | — | A | 21,911 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.
- F2Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.